Evidence map›Paper›PMID 34040505›Full record

ArticleFrontiers in cellular neuroscience2021

The Role of NF-κB Triggered Inflammation in Cerebral Ischemia.

Teresa Jover-Mengual, Jee-Yeon Hwang, Hyae-Ran Byun, Brenda L Court-Vazquez, José M Centeno, María C Burguete, R Suzanne Zukin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 57 citations in OpenAlex.

  1. Taraxerol Alleviates Cerebral Ischemia-Reperfusion Induced Inflammation and Ferroptosis via Regulating AKT/NF-κB Pathway.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Blocking S1PJournal of advanced research · 2025
    Article
  15. Article
  16. NXC736, a Functional Antagonist of S1PMolecules (Basel, Switzerland) · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Teresa Jover-MengualDominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, New York, NY, United States.
Jee-Yeon HwangDominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, New York, NY, United States.
Hyae-Ran ByunDominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, New York, NY, United States.
Brenda L Court-VazquezDominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, New York, NY, United States.
José M CentenoDepartamento de Fisiología, Universidad de Valencia, Valencia, Spain.
María C BurgueteUnidad Mixta de Investigación Cerebrovascular, Instituto de Investigación Sanitaria La Fe-Universidad de Valencia, Valencia, Spain.
R Suzanne ZukinDominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, New York, NY, United States.
Albert Einstein College of Medicine · USInstituto de Investigación Sanitaria La Fe · ESCreighton University · USUniversitat de València · ES

Funding

SUPPORT FOR THE ROSE F KENNEDY IDDRC P50P50HD105352 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Julie Secombe · 2021 to 2026
$7.0M
NICHD NIH HHS P50 HD105352
6 · The paper itself

Abstract

Cerebral ischemia is a devastating disease that affects many people worldwide every year. The neurodegenerative damage as a consequence of oxygen and energy deprivation, to date, has no known effective treatment. The ischemic insult is followed by an inflammatory response that involves a complex interaction between inflammatory cells and molecules which play a role in the progression towards cell death. However, there is presently a matter of controversy over whether inflammation could either be involved in brain damage or be a necessary part of brain repair. The inflammatory response is triggered by inflammasomes, key multiprotein complexes that promote secretion of pro-inflammatory cytokines. An early event in post-ischemic brain tissue is the release of certain molecules and reactive oxygen species (ROS) from injured neurons which induce the expression of the nuclear factor-kappaB (NF-κB), a transcription factor involved in the activation of the inflammasome. There are conflicting observations related to the role of NF-κB. While some observe that NF-κB plays a damaging role, others suggest it to be neuroprotective in the context of cerebral ischemia, indicating the need for additional investigation. Here we discuss the dual role of the major inflammatory signaling pathways and provide a review of the latest research aiming to clarify the relationship between NF-κB mediated inflammation and neuronal death in cerebral ischemia.

Indexed as

cerebral ischemiainflammationneurodegenerationneuroprotectionNF-κB

Identifiers

PMID34040505
PMCPMC8141555
OpenAlexW3160191542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.